(Q67300751)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1172258%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

title

Detection of the nueroleptic properties of clozapine, sulpiride and thioridazine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1172258%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine (English)

1 reference

19 October 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1172258

28 August 2022

1 reference

19 October 2023

author name string

B. Costall

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1172258

28 August 2022

R. J. Naylor

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1172258

28 August 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1172258

28 August 2022

publication date

1 July 1975

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1172258%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

23 July 1975

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1172258

full work available at URL

28 August 2022

http://link.springer.com/content/pdf/10.1007/BF00437617.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00437617/fulltext.html

19 October 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF00437617

19 October 2023

1 reference

19 October 2023

43

1

69–74

23 July 1975

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1172258

28 August 2022

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1172258%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1172258%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

page(s)

69-74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1172258%20AND%20SRC:MED&resulttype=core&format=json

Nomifensine: A potent dopaminergic agonist of antiparkinson potential

11 September 2019

cites work

1 reference

12 December 2020

Parkinsonism and related phenomena from administration of drugs: their production and control under clinical conditions and possible relation to therapeutic effect.

1 reference

12 December 2020

Parkinson's disease: from brain homogenate to treatment

1 reference

12 December 2020

Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism

1 reference

12 December 2020

Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects

1 reference

12 December 2020

Effect of single and repeated administration of clozapine on the metabolism of dopamine and noradrenaline in the brain of the rat.

1 reference

12 December 2020

Neuroleptics: relation between cataleptic and anti-turning actions, and role of the cholinergic system

1 reference

12 December 2020

[An original psychotropic drug: sulpiride]

1 reference

12 December 2020

Dopamine turnover in the corpus striatum and the lumbic system after treatment with neuroleptic and anti-acetylcholine drugs

1 reference

12 December 2020

[Neuropharmacological findings after chronic administration of haloperidol, loxapine and clozapine]

1 reference

12 December 2020

Clinical-neuroleptic investigation of N-((1-ethyl-pyrrolidine-2-yl)-methyl)-2-methoxy-5-sulfamyl-benzamide-neuroleptic sulpiride (Dogmatil) in acutly ill schizophrenics

1 reference

12 December 2020

Mesolimbic involvement with behavioural effects indicating antipsychotic activity

1 reference

12 December 2020

Stereotyped and circling behaviour induced by dopaminergic agonists after lesions of the midbrain raphe nuclei

1 reference

12 December 2020

Effects of clozapine on cerebral catecholaminergic neurone systems

1 reference

12 December 2020

Neuroleptic and non-neuroleptic catalepsy

1 reference

12 December 2020

Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical antipsychotic effect?

1 reference

12 December 2020

The influence of sulpiride on motor activity and vigilance in the mouse

1 reference

12 December 2020

Pimozide treatment of chronic schizophrenics as compared with haloperidol and penfluridol maintenance treatment. A multidisciplinary approach.

1 reference

12 December 2020

[Preliminary clinical experiences with sulpiride]

1 reference

12 December 2020

The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine (clozapine)

1 reference

12 December 2020

The prediction of sedative potency of neuroleptics

1 reference

12 December 2020

Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroin

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00437617

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1172258%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

1 reference